Zobrazeno 1 - 10
of 124
pro vyhledávání: '"C Zaltman"'
Autor:
F. Juliao-Baños, C.F. Grillo-Ardila, I. Alfaro, M.T. Andara-Ramírez, O. Avelar-Escobar, J. Barahona-Garrido, S. Bautista-Martínez, F.J. Bosques-Padilla, J.A. De Paula, K. Ernest-Suárez, M.T. Galiano, B. Iade-Vergara, Patricio-Ibañez, M.L. Jara-Alba, P.G. Kotze, M.C. Miranda-Ojeda, R. Ortuño-Escalante, G. Otoya-Moreno, F.N. Piñol-Jiménez, I.C. Ramos-Polo, A. Sambuelli, M. Toro, E.A. Torres, G.R. Veitia-Velásquez, J.K. Yamamoto-Furusho, C. Zaltman, F. Steinwurz, M. Vallejo-Ortega, J.I. Torres-Castillo, C. Hamon-Pinilla, C.H. Calderón-Franco, A.M. Escobar-Villegas
Publikováno v:
Revista de Gastroenterología de México, Vol 87, Iss 3, Pp 342-361 (2022)
Resumen: La colitis ulcerativa (CU) es una enfermedad crónica de etiología desconocida, incurable, su curso clínico es intermitente, caracterizado por periodos de remisión y recaídas, su prevalencia e incidencia mundial ha venido incrementando.
Externí odkaz:
https://doaj.org/article/121322e801bc45f3a665c5e0c1d48527
Autor:
F. Juliao-Baños, C.F. Grillo-Ardila, I. Alfaro, M.T. Andara-Ramírez, O. Avelar-Escobar, J. Barahona-Garrido, S. Bautista-Martínez, F.J. Bosques-Padilla, J.A. De Paula, K. Ernest-Suárez, M.T. Galiano, B. Iade-Vergara, Patricio-Ibañez, M.L. Jara-Alba, P.G. Kotze, M.C. Miranda-Ojeda, R. Ortuño-Escalante, G. Otoya- Moreno, F.N. Piñol-Jiménez, I.C. Ramos-Polo, A. Sambuelli, M. Toro, E.A. Torres, G.R. Veitia-Velásquez, J.K. Yamamoto-Furusho, C. Zaltman, F. Steinwurz, M. Vallejo-Ortega, J.I. Torres-Castillo, C. Hamon-Pinilla, C.H. Calderon-Franco, A.M. Escobar-Villegas
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 87, Iss 3, Pp 342-361 (2022)
Ulcerative colitis (US) is a chronic disease of unknown etiology. It is incurable and its clinical course is intermittent, characterized by periods of remission and relapse. The prevalence and incidence of the disease has been increasing worldwide. T
Externí odkaz:
https://doaj.org/article/fef17ef947eb4071b2938745208d767e
Autor:
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia, C. Zaltman
Publikováno v:
Revista de Gastroenterología de México, Vol 82, Iss 2, Pp 134-155 (2017)
Este es el primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation (PANCCO) que corresponde a situaciones especiales en pacientes con enfermedad inflamatoria intestinal (EII). El objetivo de este consenso es concientizar a
Externí odkaz:
https://doaj.org/article/6c2b4dee93e641cd8b5c5ed3738eeced
Autor:
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia, C. Zaltman
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 82, Iss 2, Pp 134-155 (2017)
This is the first Latin American Consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) regarding special situations in patients with inflammatory bowel disease (IBD). The aim of this consensus is to raise awareness in the medical co
Externí odkaz:
https://doaj.org/article/c20061f561b84f9baa8b6b0d74a069c8
Autor:
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia, C. Zaltman
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 82, Iss 1, Pp 46-84 (2017)
The incidence and prevalence of inflammatory bowel disease (IBD) has increased in recent years in several Latin American countries. There is a need to raise awareness in gastroenterologists and the population in general, so that early diagnosis and t
Externí odkaz:
https://doaj.org/article/1873a0000f19408fab38359c8df743b0
Autor:
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia, C. Zaltman
Publikováno v:
Revista de Gastroenterología de México, Vol 82, Iss 1, Pp 46-84 (2017)
La incidencia y la prevalencia de la enfermedad inflamatoria intestinal (EII) se han incrementado en los últimos años en varios países de Latinoamérica. Existe una necesidad de concientizar a gastroenterólogos y a la población en general para p
Externí odkaz:
https://doaj.org/article/f0eb7efa6e29408f9dab26977e8c14a5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R Froes, A R Andrade, M A G Faria, R S Parra, C Zaltman, H S P Souza, C H M D S Santos, M Bafutto, A B Quaresma, G O Santana, R L Rafael Luís Luporini, S F D Lima Junior, S J Miszputen, M M D Souza, G S P Herrerias, R L Kaiser Junior, C R D Nascimento, O Féres, J R D Barros, C D S Guimarães, L Y Sassaki, R Saad-Hossne
Publikováno v:
Journal of Crohn's and Colitis. 17:i963-i963
Background Brazil has shown an increase in Inflammatory Bowel Disease (IBD) cases. GEDIIB (Brazilian Organization of Crohn's Disease and Colitis) established a data platform to create a national registry of IBD patients. The study aimed to characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f775baece453c899ae1a2b01a6a41e9
https://doi.org/10.1093/ecco-jcc/jjac190.0961
https://doi.org/10.1093/ecco-jcc/jjac190.0961
Autor:
R.M. Bartholo, C. Zaltman, C. Elia, A.P. Cardoso, V. Flores, P. Lago, L. Cassabian, F. Carvalho Dorileo, J.R. Lapa-e-Silva
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 38, Iss 2, Pp 197-203 (2005)
With the aim of investigating the presence of latent inflammatory process in the lungs of patients with Crohn's disease, 15 patients with Crohn's disease were evaluated by spirometry, the methacholine challenge test, induced sputum, and skin tests fo
Externí odkaz:
https://doaj.org/article/de9b60a4c33740dfa1848502406cd3c6
Autor:
S Y Wong, D Helmus, L Marlow, V Martinez Pazos, S Brann, J Wellens, S Kedia, J W Y Mak, D Bergemalm, M Argollo, C Zaltman, F Steinwurz, D Rubin, M Allez, J Halfvarson, M T Abreu, J Lindsay, U Dutta, M S Silverberg, S C Ng, V Ahuja, K Watanabe, S Vermeire, J F Colombel, J Satsangi
Publikováno v:
Journal of Crohn's and Colitis. 16:i357-i358
Background IBD patients on immune-modulatory therapies are considered high-risk for SARS-CoV-2 infection. Direct comparisons of serological responses to SARS-CoV-2 infection in IBD patients across different continents and medications are lacking. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7846908c03f2f4c90714a296abb51f68
https://doi.org/10.1093/ecco-jcc/jjab232.469
https://doi.org/10.1093/ecco-jcc/jjab232.469